Skip to main content

Animations

MJFF Publications

3441 - 3450 of 6431 Results
Title
Year
  • Year
  • 2020
  • 2019
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-202047
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Clinical Trial Highlights – Infusion Therapies
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-199005
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Perceptions of Compensation Strategies for Gait Impairments in Parkinson’s Disease: A Survey Among 320 Healthcare Professionals
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-202176
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191896
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Orofacial pain in 1916 patients with early or moderate Parkinson disease
    Journal Name: PAIN Reports
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1097/pr9.0000000000000923
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    Journal Name: Pharmacogenetics and Genomics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab404
    Citation Count: 82
  • Summary Details
    OPEN
    Title: An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bib/bbab522
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network
    Journal Name: Cerebral Cortex
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/cercor/bhab148
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlaa153
    Citation Count: 57
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.